Q/C Technologies, Inc. (QCLS)
1.79
-0.09
(-4.79%)
USD |
NASDAQ |
Sep 04, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
Q/C Technologies Shareholders Equity (Quarterly) : 19.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.07M |
| March 31, 2026 | 23.69M |
| December 31, 2025 | 24.73M |
| September 30, 2025 | 21.32M |
| June 30, 2025 | 11.60M |
| March 31, 2025 | 13.84M |
| December 31, 2024 | 14.72M |
| September 30, 2024 | 17.06M |
| June 30, 2024 | 0.3823M |
| March 31, 2024 | 10.24M |
| December 31, 2023 | 12.77M |
| September 30, 2023 | 16.11M |
| June 30, 2023 | 11.50M |
| March 31, 2023 | 13.09M |
| December 31, 2022 | 14.70M |
| September 30, 2022 | 18.33M |
| June 30, 2022 | 16.12M |
| March 31, 2022 | 19.62M |
| December 31, 2021 | 23.65M |
| September 30, 2021 | 25.89M |
| June 30, 2021 | 31.07M |
| March 31, 2021 | 33.42M |
| December 31, 2020 | 34.58M |
| September 30, 2020 | 21.17M |
| June 30, 2020 | 15.97M |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | 9.355M |
| September 30, 2019 | 3.598M |
| June 30, 2019 | 4.314M |
| March 31, 2019 | 4.966M |
| December 31, 2018 | 5.834M |
| September 30, 2018 | 7.719M |
| June 30, 2018 | 10.79M |
| March 31, 2018 | 11.42M |
| December 31, 2017 | 7.553M |
| September 30, 2017 | 3.795M |
| June 30, 2017 | 4.964M |
| March 31, 2017 | 5.747M |
| December 31, 2016 | 3.388M |
| September 30, 2016 | 4.470M |
| June 30, 2016 | 4.118M |
| March 31, 2016 | 5.111M |
| December 31, 2015 | 6.603M |
| September 30, 2015 | 9.798M |
| June 30, 2015 | 12.12M |
| March 31, 2015 | 14.21M |
| December 31, 2014 | 14.81M |
| September 30, 2014 | 15.73M |
| June 30, 2014 | 16.66M |
| March 31, 2014 | 16.62M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.87M |
| Total Liabilities (Quarterly) | 3.792M |
| Debt to Equity Ratio | 0.0195 |
| Current Ratio | 3.293 |
| Net Debt Paydown Yield | -0.23% |